foxo4 dri patent FOXO4-DRI Research Peptide – 15mg The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Buy FOXO4 DRI 15mg Paramount Peptides FOXO4 DRI 10mg vial Description RCpeptides
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



